Mouse models of Parkinson's disease associated with mitochondrial dysfunction

Alicia M Pickrell1, Milena Pinto, Carlos T Moraes

  • 1Neuroscience Graduate Program, University of Miami, Miller School of Medicine, Miami, FL 33136, USA.

Insights

Parkinson's disease (PD) research highlights mitochondrial dysfunction. Mouse models with genetic defects offer insights into PD pathogenesis and therapeutic testing for neurodegenerative diseases.

Area of Science:

  • Neuroscience
  • Genetics
  • Mitochondrial Biology

Background:

  • Parkinson's disease (PD) pathogenesis remains incompletely understood despite extensive research.
  • Genetic studies in rare familial PD cases implicate mitochondrial dysfunction.
  • Mitochondrial dysfunction is increasingly recognized as a key factor in neurodegeneration.

Purpose of the Study:

  • To review the characteristics of mouse models relevant to Parkinson's disease.
  • To explore how these models aid in understanding PD.
  • To assess their utility in preclinical therapeutic testing.

Main Methods:

  • Review of existing literature on PD mouse models.
  • Analysis of models with genetic alterations affecting mitochondrial function.
  • Discussion of phenotypic outcomes and relevance to PD.

Main Results:

  • Genetic mouse models with affected mitochondrial genes provide valuable insights into PD.
  • These models recapitulate aspects of PD pathology, aiding mechanistic studies.
  • They serve as crucial platforms for evaluating potential PD treatments.

Conclusions:

  • Mouse models are indispensable tools for advancing Parkinson's disease research.
  • Targeting mitochondrial dysfunction is a promising therapeutic strategy for PD.
  • Further characterization of these models will accelerate the development of effective PD therapies.

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...